Best Pure Play Investment in Cancer Drugs
Global cancer drug sales could soon soar past $100 billion, making this pure play in cancer drugs a stock you should seriously consider owning.
1 Small-Cap Biotech Stock to Buy and Hold For the Next 10 Years
Small cap biotech stocks have a lot of inherent risk, but if you can snag a winner your returns could double many times over. Here's one small-cap biotech stock you can consider buying and holding for the next 10 years.
5 Promising Biotech Stocks Under $10
Don't let their share price fool you. These five biotech stocks have the potential to double your money many times over if their product pipelines meet expectations.